An interventional study of Nurse-Led Telehealth-Supported Multicomponent Frailty Management Program in Frailty, sponsored by Kutahya Health Sciences University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.
Sponsored by Kutahya Health Sciences University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 83 studies in Frailty with a site in Turkey — 24 open to participants now, 27 under way, none of them phase 3. Frailty · Turkey.
Among the 83 studies in Frailty with a site in Turkey, this one is the 2nd largest by enrollment of the 16 interventional ones that give a count, is one of 25 that started in 2026, is one of 16 with no phase, and was the 69th registered.
1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.
Browse Frailty studies →24 of the 83 studies in Frailty with a site in Turkey are open now. Recruiting first, the newest first:
Konya City Hospital · Sites in Turkey
Ages 65+
Kocaeli City Hospital · Sites in Turkey
Ages 65+
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18+
Konya City Hospital · Sites in Turkey
Ages 18+
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Sites in Turkey
Ages 65–70
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
83 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 25 started in 2026.
This study's enrollment of 122 is above the median of 83 across 772 interventional studies indexed under Frailty.
Median enrollment 64 across the 16 interventional studies, 138 across the 67 observational. Of the 51 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 83 has an industry lead sponsor. The 10 most frequent:
Kutahya Health Sciences University is the lead sponsor of 219 studies on the registry; 48 are open to participants now.
Kutahya Health Sciences University has 1 study filed under Frailty — fewer than ten, so there is no comparison to draw.
12 of the studies in Frailty with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07813702MERT UYSALURINARY INCONTINENCE AND GERIATRIC SYNDROMES | 2026-11 |
| NCT07677072Kanuni Sultan Suleyman Training and Research HospitalCan Serum Lumican Level Identify a Hidden Fragility Phenotype Beyond Bone Mineral Density in Postmenopausal Women? | 2026-12-01 |
| NCT07463352Duzce UniversityPreoperative Oral Nutrition And Outcomes In Frail Elderly Patients With Femur Fractures | 2027-01-01 |
| NCT07458048Istanbul University - CerrahpasaComparıson of the Effıcacy of Conventıonal Exercıse and Pılates ın Pre-fraıl and Fraıl Older Adults | 2027-02 |
| NCT07642765Konya City HospitalEASIX Score and Post-Induction Hypotension in Frail Patients Undergoing Non-Cardiac Surgery | 2027-02-01 |
Add all 12 to your calendar (.ics) → With an account.
Among the 83 studies in Frailty with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Frailty can make older adults more vulnerable to loss of independence, falls, and hospitalization. This study evaluated whether a six-week nurse-led telephone education and counseling program could improve frailty and daily functioning in older adults living at home.
This single-center, two-arm, parallel-group randomized controlled trial included 122 adults aged 65 years or older who were frail or at risk of frailty and received home care services. Participants were randomly assigned to the intervention group or the usual care group, with 61 participants in each group.
Both groups continued to receive routine monthly home care. In addition, the intervention group received an initial face-to-face session followed by weekly telephone education and counseling sessions lasting approximately 20 to 25 minutes for six weeks. No additional intervention education or counseling was provided during weeks 7 to 18.
The primary outcome was frailty measured using the FRAIL Scale. Secondary outcomes included ability to perform instrumental activities of daily living, depressive symptoms, falls, emergency department visits, and hospitalizations. Frailty, daily functioning, and depressive symptoms were assessed at baseline, week 6, and week 18. Falls and health care use were recorded during the 18-week follow-up period. Outcome assessment and statistical analysis were conducted with treatment-group masking.
The study was conducted through a hospital-based home care unit in Kütahya, Türkiye.
The intervention was delivered by a nurse with a master's degree. It began with an individual face-to-face assessment and education session lasting approximately 20 to 25 minutes, followed by one telephone education and counseling session per week for six weeks. Each telephone session lasted approximately 20 to 25 minutes.
The program addressed frailty awareness, safe physical activity and mobility, nutrition and fluid intake, fall prevention and home safety, medication and chronic disease self-management, sleep and fatigue management, social support, and healthy daily routines. Education and counseling were individualized to participants' needs and supported by an educational booklet and an individual action plan. A standardized checklist was used to document delivery of the intervention content and completion of the sessions. No additional intervention education or counseling was provided during weeks 7 to 18.
Participants in both groups continued routine monthly hospital-based home care services, including assessment of general health, blood pressure, pulse, body temperature, and pressure injuries. Adverse events were monitored weekly in both groups. Reports of deaths were obtained from relatives and reviewed alongside available health records.
Face-to-face outcome assessments were performed at baseline, week 6, and week 18 by a researcher who was unaware of group allocation. Frailty was assessed with the FRAIL Scale, functional status with the Lawton-Brody Instrumental Activities of Daily Living Scale, and depressive symptoms with the 15-item Geriatric Depression Scale. Falls, emergency department visits, and hospitalizations were recorded during follow-up.
Randomization and statistical analysis were performed by different researchers. The statistical analyst received groups coded as A and B and remained unaware of the intervention and control labels during the main analyses. Measurements obtained before withdrawal or death were retained; no measurements were imputed after death.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants received a six-week nurse-led telehealth-supported frailty management program in addition to routine monthly home care. A nurse with a master's degree delivered an initial face-to-face assessment and education session, followed by weekly telephone education and counseling sessions lasting approximately 20 to 25 minutes. An educational booklet and an individual action plan supported the intervention. Session completion and content delivery were documented using a standardized checklist. No additional intervention education or counseling was provided during weeks 7 to 18.
Behavioral: Nurse-Led Telehealth-Supported Multicomponent Frailty Management Program
Participants continued routine monthly hospital-based home care, including assessment of general health, blood pressure, pulse, body temperature, and pressure injuries. They did not receive the structured frailty education and telephone counseling program. Outcome assessments and weekly adverse event monitoring followed the same schedule as in the intervention group.
A six-week individualized education and counseling program delivered by a nurse with a master's degree. An initial face-to-face session and weekly telephone sessions each lasted approximately 20 to 25 minutes. Content addressed frailty awareness, safe physical activity and mobility, nutrition and fluid intake, fall prevention and home safety, medication and chronic disease self-management, sleep and fatigue management, social support, and healthy daily routines. An educational booklet and an individual action plan supported delivery. A standardized checklist documented session completion and content delivery. No additional intervention education or counseling was provided during weeks 7 to 18.
Frailty Level Assessed by the FRAIL Scale
Frailty level will be assessed using the FRAIL Scale. The FRAIL Scale consists of five components: fatigue, resistance, ambulation, illnesses, and weight loss. Total scores range from 0 to 5. Higher scores indicate greater frailty. A score of 0 indicates robust status, scores of 1 to 2 indicate pre-frailty, and scores of 3 to 5 indicate frailty.
Time frame: Baseline, 6 weeks, and 18 weeks
Functional Status Assessed by the Lawton-Brody Instrumental Activities of Daily Living Scale
Functional status will be assessed using the Lawton-Brody Instrumental Activities of Daily Living Scale. Total scores range from 0 to 8. Higher scores indicate greater independence in instrumental activities of daily living.
Time frame: Baseline, 6 weeks, and 18 weeks
Depressive Symptoms Assessed by the 15-Item Geriatric Depression Scale
Depressive symptoms will be assessed using the 15-item Geriatric Depression Scale. Total scores range from 0 to 15. Higher scores indicate more severe depressive symptoms. Scores of 0 to 4 indicate no depression, 5 to 8 indicate mild depression, 9 to 11 indicate moderate depression, and 12 to 15 indicate severe depression.
Time frame: Baseline, 6 weeks, and 18 weeks
Number of Falls During the Study Period
The number of falls experienced by participants during the study period will be recorded using a fall and health care utilization form developed by the researchers. Data will be based on participant self-report. A higher number indicates more falls.
Time frame: From baseline to 18 weeks
Number of Emergency Department Visits During the Study Period
The number of emergency department visits during the study period will be recorded using a health care utilization form developed by the researchers. Data will be based on participant self-report. A higher number indicates greater emergency health care utilization.
Time frame: From baseline to 18 weeks
Number of Hospitalizations During the Study Period
The number of hospitalizations during the study period will be recorded using a health care utilization form developed by the researchers. Data will be based on participant self-report. A higher number indicates greater hospital utilization.
Time frame: From baseline to 18 weeks
Plan to share: Yes — De-identified individual participant data underlying the findings reported in the main publication, together with the associated data dictionary, will be made available to researchers upon reasonable request to the corresponding author for 5 years following publication of the main study article. The data will not be posted publicly to protect participant privacy. Access will be subject to applicable ethical and participant-consent requirements.
Supporting information: Study protocol, Statistical analysis plan, Analytic code
Time frame: Data will be available from publication of the main study article and will remain available for 5 years.
Access criteria: Researchers may request access by emailing Serkan Budak at serkan.budak@ksbu.edu.tr and describing the research question, intended analyses, and data required. The corresponding author will review requests for scientific relevance, participant confidentiality, and compliance with applicable ethical and consent requirements. Approved requests will receive de-identified data and the associated data dictionary.
Ran from Jun 2026 to primary completion in Oct 2026, 4 months.
Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's 4 months is below that.
Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kutahya Health Sciences University →